Search PepX: Orthogonal Bundle
Results 1 - 50 of 144
Results
| PDB Identifier | Description | Ligand | Receptor | SCOP | pdb.org | |
|---|---|---|---|---|---|---|
  |
1A2X | COMPLEX OF TROPONIN C WITH A 47 RESIDUE (1-47) FRAGMENT OF TROPONIN I | B | A | EF Hand-like |
 |
  |
1BT6 | P11 (S100A10), LIGAND OF ANNEXIN II IN COMPLEX WITH ANNEXIN II N-TERMINUS | C | A | EF Hand-like |
|
  |
1CDM | MODULATION OF CALMODULIN PLASTICITY IN MOLECULAR RECOGNITION ON THE BASIS OF X-RAY STRUCTURES | B | A |
|
|
  |
1CM1 | MOTIONS OF CALMODULIN-SINGLE-CONFORMER REFINEMENT | B | A | EF Hand-like |
|
  |
1CM4 | MOTIONS OF CALMODULIN-FOUR-CONFORMER REFINEMENT | B | A | EF Hand-like |
|
  |
1EMU | STRUCTURE OF THE AXIN RGS-HOMOLOGOUS DOMAIN IN COMPLEX WITH A SAMP REPEAT FROM APC | B | A | Regulator of G-protein signaling. RGS |
|
  |
1EYX | CRYSTAL STRUCTURE OF R-PHYCOERYTHRIN AT 2.2 ANGSTROMS | G | B | Globin-like |
|
  |
1FM6 | THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES. | B | A | Nuclear receptor ligand-binding domain |
|
  |
1FM9 | THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES. | B | A | Nuclear receptor ligand-binding domain |
|
  |
1GUX | RB POCKET BOUND TO E7 LXCXE MOTIF | E | B | Cyclin-like |
|
  |
1GWQ | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE | C | A | Nuclear receptor ligand-binding domain |
|
  |
1GWR | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE | C | A | Nuclear receptor ligand-binding domain |
|
  |
1H24 | CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F | E | B | Cyclin-like |
|
  |
1H25 | CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN | E | B | Cyclin-like |
|
  |
1H26 | CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53 | E | B | Cyclin-like |
|
  |
1H27 | CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27 | E | B | Cyclin-like |
|
  |
1IQ5 | Calmodulin/nematode CA2+/Calmodulin dependent kinase kinase fragment | B | A | EF Hand-like |
|
  |
1IWQ | Crystal Structure of MARCKS calmodulin binding domain peptide complexed with Ca2+/Calmodulin | B | A | EF Hand-like |
|
  |
1J2X | Crystal structure of RAP74 C-terminal domain complexed with FCP1 C-terminal peptide | B | A | DNA/RNA-binding 3-helical bundle |
|
  |
1JD5 | Crystal Structure of DIAP1-BIR2/GRIM | B | A | Inhibitor of apoptosis (IAP) repeat |
|
  |
1K4W | X-ray structure of the orphan nuclear receptor ROR beta ligand-binding domain in the active conformation | B | A | Nuclear receptor ligand-binding domain |
|
  |
1K74 | The 2.3 Angstrom resolution crystal structure of the heterodimer of the human PPARgamma and RXRalpha ligand binding domains respectively bound with GW409544 and 9-cis retinoic acid and co-activator peptides. | B | A | Nuclear receptor ligand-binding domain |
|
  |
1K7L | The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide. | B | A | Nuclear receptor ligand-binding domain |
|
  |
1L2I | Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide | C | A | Nuclear receptor ligand-binding domain |
|
  |
1L7Z | Crystal structure of Ca2+/Calmodulin complexed with myristoylated CAP-23/NAP-22 peptide | B | A | EF Hand-like |
|
  |
1M2Z | Crystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain bound to dexamethasone and a TIF2 coactivator motif | B | A | Nuclear receptor ligand-binding domain |
|
  |
1M45 | CRYSTAL STRUCTURE OF MLC1P BOUND TO IQ2 OF MYO2P, A CLASS V MYOSIN | B | A | EF Hand-like |
|
  |
1M46 | CRYSTAL STRUCTURE OF MLC1P BOUND TO IQ4 OF MYO2P, A CLASS V MYOSIN | B | A | EF Hand-like |
|
  |
1MV9 | Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa Hexaenoic Acid) and a coactivator peptide | B | A | Nuclear receptor ligand-binding domain |
|
  |
1MVC | Crystal structure of the human RXR alpha ligand binding domain bound to the synthetic agonist compound BMS 649 and a coactivator peptide | B | A | Nuclear receptor ligand-binding domain |
|
  |
1MXE | Structure of the Complex of Calmodulin with the Target Sequence of CaMKI | E | A | EF Hand-like |
|
  |
1MZN | CRYSTAL STRUCTURE at 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE | B | A | Nuclear receptor ligand-binding domain |
|
  |
1N4H | Characterization of ligands for the orphan nuclear receptor RORbeta | B | A | Nuclear receptor ligand-binding domain |
|
  |
1N4M | Structure of Rb tumor suppressor bound to the transactivation domain of E2F-2 | C | A | Cyclin-like |
|
  |
1NIW | Crystal structure of endothelial nitric oxide synthase peptide bound to calmodulin | B | A | EF Hand-like |
|
  |
1NQ7 | Characterization of ligands for the orphan nuclear receptor RORbeta | B | A | Nuclear receptor ligand-binding domain |
|
  |
1NRL | Crystal Structure of the human PXR-LBD in complex with an SRC-1 coactivator peptide and SR12813 | C | A | Nuclear receptor ligand-binding domain |
|
  |
1NX0 | Structure of Calpain Domain 6 in Complex with Calpastatin DIC | E | A | EF Hand-like |
|
  |
1NX1 | Calpain Domain VI Complexed with Calpastatin Inhibitory Domain C (DIC) | C | A | EF Hand-like |
|
  |
1OAI | COMPLEX BETWEEN TAP UBA DOMAIN AND FXFG NUCLEOPORIN PEPTIDE | B | A | RuvA C-terminal domain-like |
|
  |
1OKV | CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2 | E | B | Cyclin-like |
|
  |
1OSV | STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR | C | A | Nuclear receptor ligand-binding domain |
|
  |
1PQ1 | Crystal structure of Bcl-xl/Bim | B | A |
|
|
  |
1PZL | Crystal structure of HNF4a LBD in complex with the ligand and the coactivator SRC-1 peptide | B | A | Nuclear receptor ligand-binding domain |
|
  |
1QLS | S100C (S100A11),OR CALGIZZARIN, IN COMPLEX WITH ANNEXIN I N-TERMINUS | D | A | EF Hand-like |
|
  |
1QTX | THE 1.65 ANGSTROM STRUCTURE OF CALMODULIN RS20 PEPTIDE COMPLEX | B | A | Calmodulin |
|
  |
1RDT | Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer | E | D | Nuclear receptor ligand-binding domain |
|
  |
1RJK | crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MD and a synthetic peptide containing the NR2 box of DRIP 205 | C | A | Nuclear receptor ligand-binding domain |
|
  |
1RK3 | crystal structure of the rat vitamin D receptor ligand binding domain complexed with 1,25-dihydroxyvitamin D3 and a synthetic peptide containing the NR2 box of DRIP 205 | C | A | Nuclear receptor ligand-binding domain |
|
  |
1RKG | crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MbisP and a synthetic peptide containing the NR2 box of DRIP 205 | C | A | Nuclear receptor ligand-binding domain |
|
